Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position.
暂无分享,去创建一个
Xingzhi Xu | Ying Zhang | J. Liao | Sheng-li Cao | Xue-jun Tang | Ting-Ting Ren | Chao-Rui Yang | Man Gao
[1] M. Akhter,et al. Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. , 2015, European journal of medicinal chemistry.
[2] N. Shankaraiah,et al. Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: synthesis, DNA-binding affinity and cytotoxic activity. , 2015, Bioorganic chemistry.
[3] R. Konwar,et al. Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway. , 2014, European journal of medicinal chemistry.
[4] P. Depreux,et al. Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors. , 2014, European journal of medicinal chemistry.
[5] D. Mobley,et al. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. , 2013, Journal of medicinal chemistry.
[6] S. W. Park,et al. An evolving role of piperazine moieties in drug design and discovery. , 2013, Mini reviews in medicinal chemistry.
[7] Xingzhi Xu,et al. Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one. , 2013, Bioorganic & medicinal chemistry letters.
[8] Xingzhi Xu,et al. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline. , 2013, European journal of medicinal chemistry.
[9] T. Szekeres,et al. Synthesis antimicrobial and anticancer activity of N′-arylmethylidene-piperazine-1-carbothiohydrazide , 2013, Medicinal Chemistry Research.
[10] Xiao-Jing Shi,et al. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. , 2013, European journal of medicinal chemistry.
[11] C. Teng,et al. Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells , 2013, Annals of Hematology.
[12] S. Belinsky,et al. A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies , 2012, Cancer Chemotherapy and Pharmacology.
[13] D. Gandara,et al. A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma , 2011, International Journal of Clinical Oncology.
[14] Wei Huang,et al. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. , 2009, European journal of medicinal chemistry.
[15] K. Rangappa,et al. Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. , 2009, European journal of medicinal chemistry.
[16] W. Guo,et al. Effect of TM208 on QGY-7703 xenograft tumor growth , 2008, Anti-cancer drugs.
[17] U. Jordis,et al. Improved synthesis of substituted 6,7-dihydroxy-4-quinazolineamines: tandutinib, erlotinib and gefitinib. , 2006, Molecules.
[18] Yuyang Jiang,et al. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains. , 2005, Bioorganic & medicinal chemistry letters.
[19] Donna Neuberg,et al. CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). , 2002, Cancer cell.